Boston Financial Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $2.02M | Sell |
7,735
-688
| -8% | -$204K | 0.06% | 147 |
|
|
2024
Q3 | $2.71M | Sell |
8,423
-123
| -1% | -$40.2K | 0.08% | 128 |
|
|
2024
Q2 | $2.67M | Sell |
8,546
-202
| -2% | -$59.3K | 0.08% | 127 |
|
|
2024
Q1 | $2.49M | Sell |
8,748
-50
| -0.6% | -$14.6K | 0.08% | 129 |
|
|
2023
Q4 | $2.53M | Sell |
8,798
-470
| -5% | -$128K | 0.09% | 127 |
|
|
2023
Q3 | $2.49M | Sell |
9,268
-359
| -4% | -$89.6K | 0.09% | 124 |
|
|
2023
Q2 | $2.14M | Sell |
9,627
-1,272
| -12% | -$295K | 0.08% | 136 |
|
|
2023
Q1 | $2.63M | Sell |
10,899
-101
| -0.9% | -$24.8K | 0.1% | 122 |
|
|
2022
Q4 | $2.89M | Buy |
11,000
+92
| +0.8% | +$24.7K | 0.12% | 113 |
|
|
2022
Q3 | $2.46M | Buy |
10,908
+86
| +0.8% | +$20.8K | 0.11% | 114 |
|
|
2022
Q2 | $2.63M | Buy |
10,822
+366
| +4% | +$89.7K | 0.11% | 107 |
|
|
2022
Q1 | $2.53M | Sell |
10,456
-1,099
| -10% | -$253K | 0.1% | 116 |
|
|
2021
Q4 | $2.6M | Buy |
11,555
+2,112
| +22% | +$446K | 0.09% | 101 |
|
|
2021
Q3 | $2.01M | Buy |
9,443
+620
| +7% | +$143K | 0.08% | 105 |
|
|
2021
Q2 | $2.15M | Sell |
8,823
-1,100
| -11% | -$271K | 0.09% | 101 |
|
|
2021
Q1 | $2.47M | Sell |
9,923
-1,955
| -16% | -$466K | 0.11% | 90 |
|
|
2020
Q4 | $2.73M | Sell |
11,878
-761
| -6% | -$175K | 0.12% | 86 |
|
|
2020
Q3 | $3.21M | Sell |
12,639
-559
| -4% | -$138K | 0.16% | 81 |
|
|
2020
Q2 | $3.11M | Sell |
13,198
-884
| -6% | -$202K | 0.17% | 81 |
|
|
2020
Q1 | $2.85M | Sell |
14,082
-2,766
| -16% | -$604K | 0.18% | 82 |
|
|
2019
Q4 | $4.06M | Sell |
16,848
-75
| -0.4% | -$16.5K | 0.22% | 88 |
|
|
2019
Q3 | $3.27M | Sell |
16,923
-50
| -0.3% | -$9.6K | 0.19% | 97 |
|
|
2019
Q2 | $3.13M | Sell |
16,973
-692
| -4% | -$124K | 0.18% | 99 |
|
|
2019
Q1 | $3.36M | Sell |
17,665
-2,158
| -11% | -$412K | 0.2% | 99 |
|
|
2018
Q4 | $3.86M | Sell |
19,823
-2,884
| -13% | -$563K | 0.27% | 91 |
|
|
2018
Q3 | $4.71M | Buy |
22,707
+2,030
| +10% | +$400K | 0.28% | 95 |
|
|
2018
Q2 | $3.82M | Sell |
20,677
-340
| -2% | -$60.1K | 0.26% | 99 |
|
|
2018
Q1 | $3.58M | Sell |
21,017
-3,054
| -13% | -$561K | 0.24% | 106 |
|
|
2017
Q4 | $4.19M | Sell |
24,071
-359
| -1% | -$63.5K | 0.28% | 103 |
|
|
2017
Q3 | $4.55M | Sell |
24,430
-290
| -1% | -$51.4K | 0.32% | 102 |
|
|
2017
Q2 | $4.26M | Sell |
24,720
-1,510
| -6% | -$246K | 0.31% | 108 |
|
|
2017
Q1 | $4.3M | Sell |
26,230
-1,915
| -7% | -$318K | 0.32% | 106 |
|
|
2016
Q4 | $4.12M | Sell |
28,145
-3,325
| -11% | -$500K | 0.32% | 101 |
|
|
2016
Q3 | $5.25M | Sell |
31,470
-3,625
| -10% | -$613K | 0.43% | 92 |
|
|
2016
Q2 | $5.34M | Buy |
35,095
+3,615
| +11% | +$562K | 0.44% | 92 |
|
|
2016
Q1 | $4.72M | Sell |
31,480
-810
| -3% | -$120K | 0.71% | 54 |
|
|
2015
Q4 | $5.24M | Sell |
32,290
-5
| -0% | -$786 | 0.75% | 45 |
|
|
2015
Q3 | $4.47M | Sell |
32,295
-317
| -1% | -$50K | 0.63% | 54 |
|
|
2015
Q2 | $5.01M | Sell |
32,612
-655
| -2% | -$105K | 0.64% | 48 |
|
|
2015
Q1 | $5.32M | Buy |
33,267
+557
| +2% | +$87.7K | 0.67% | 49 |
|
|
2014
Q4 | $5.21M | Buy |
32,710
+457
| +1% | +$71.2K | 0.65% | 50 |
|
|
2014
Q3 | $4.53M | Buy |
32,253
+2,751
| +9% | +$359K | 0.59% | 54 |
|
|
2014
Q2 | $3.49M | Sell |
29,502
-7,587
| -20% | -$878K | 0.46% | 68 |
|
|
2014
Q1 | $4.58M | Buy |
37,089
+2,685
| +8% | +$326K | 0.61% | 55 |
|
|
2013
Q4 | $3.92M | Buy |
34,404
+1,780
| +5% | +$202K | 0.54% | 59 |
|
|
2013
Q3 | $3.65M | Buy |
32,624
+2,415
| +8% | +$262K | 0.55% | 59 |
|
|
2013
Q2 | $2.98M | Buy |
+30,209
| New | +$3.13M | 0.46% | 66 |
|
Other funds holding AMGN
Boston Financial Management's AMGN Position: Q4 2024 in Review
Boston Financial Management reduced its Amgen (AMGN) stake by 8.2% in Q4 2024, selling an estimated $204K and leaving 7,735 shares worth $2.02M. The position accounts for 0.06% of the portfolio, ranked #147.
Boston Financial Management first reported a position in AMGN in Q2 2013 and has held it in 47 quarters since. The position peaked at $5.34M in Q2 2016. 2,856 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.
- Boston Financial Management held 7,735 shares of Amgen worth $2.02M as of Q4 2024.
- Boston Financial Management sold 688 Amgen shares in Q4 2024, an estimated $204K.
- Amgen made up 0.06% of Boston Financial Management's portfolio in Q4 2024, its #147 holding.
- Boston Financial Management first reported a position in Amgen in Q2 2013 and has held it in 47 quarters since.
- Boston Financial Management's Amgen position peaked at $5.34M in Q2 2016.
- 2,856 funds tracked by Wall St. Rank held Amgen as of Q4 2024.
Based on Boston Financial Management's 13F filing for Q4 2024, filed 3 Feb 2025.